Comparison · what each one is for

Laevitas vs INDICIA: options data vs a public track record

Laevitas is one of the most complete crypto derivatives data platforms: options, perpetuals and dated futures across 15+ exchanges, five years of history, an API and an MCP server for AI agents. If you searched for a "Laevitas alternative", the honest first answer is that for raw data depth there are few. This page explains where we differ, and when you should simply stay with Laevitas.

🧭 The verdict up front: Laevitas gives you the data: chains, Greeks, skew, GEX, max pain, across many venues and assets. INDICIA covers only BTC and ETH, but every level we show is checked against the settlement and the result is published, hit or miss. On 466 expiries, max pain landed within 1% of settlement only 37% of the time. We publish that number. We did not find a comparable published record on Laevitas.

Side by side

honest, dimension by dimension · checked 24 Oct 2026

	Laevitas	INDICIA
Coverage	15+ exchanges, 1000+ assets: options, perpetuals, dated futures, order books	BTC and ETH only: Deribit options (max pain cross-checked on Bybit) plus the top Hyperliquid whale wallets
Options analytics	Chains, Greeks, IV, skew, term structure, GEX, max pain, flows incl. blocks and strategies	Max pain and option walls · dealer gamma and regime · volatility (DVOL) history since Jan 2024
Track record	A data platform; we found no published hit/miss record of its levels	Public ledger: 466 expiries since 07.03.2026, updated after every settlement, never edited after the fact
Interpretation	Tools to build your own: strategy builder, backtesting, custom dashboards	A daily written Radar on what the levels mean, plus a public journal of failed hypotheses
API and agents	REST, WebSocket, MCP server; historical API on Enterprise	No API: we sell readings, not the raw database
Alerts	Not listed in its plans	8 free Telegram alerts (whale liquidation ≥$1M, max pain shift and more)
Price	Free (1 week of history) · Premium $50/mo per seat · Enterprise $500/mo per seat	Live boards free · Agent $39/mo · Analyst $99/mo · Expiry Brief $15/mo

Prices from laevitas.ch/pricing and our pricing page, 24 Oct 2026. Similar comparisons: Coinglass vs INDICIA · Coinalyze vs INDICIA.

What Laevitas does better

Credit where it is due, and here it is a lot.

🌐 Breadth. Many venues and hundreds of assets. We do not touch altcoin options at all.

📈 Depth of the volatility layer. Skew and term structure across venues, intraday. Our volatility work is narrower: DVOL and regimes for BTC and ETH.

📦 Data you can take away. CSV exports from Premium, an API, tick data, an MCP server. We do not sell raw data at any level.

🛠 Build-your-own tools. Strategy builder, backtesting, spread analysis, custom dashboards. If you run a desk or your own models, Laevitas is the better fit.

Where INDICIA is different: we publish the misses

Every max pain dashboard shows the level. Almost none shows how often the level was right. We keep a public ledger of every BTC and ETH expiry since 07.03.2026, with forecasts frozen 24 hours before settlement and graded against the official settlement:

🎯 max pain landed within 1% of settlement in 37% of 466 expiries. Yesterday's spot missed by less than max pain did.

📏 our market-maker breakeven range held 82% of settlements, but a plain band of the same width around yesterday's price held 89%. We print that too, because the band beat us.

So we treat max pain as a reference level, not a magnet, and we tell you before you pay. The full ledger is free: Does max pain work? 466 expiries on trial.

When to choose which

Choose Laevitas if you need raw data, many venues or altcoins, an API, backtesting or a full volatility surface.

Choose INDICIA if you trade BTC or ETH and want a daily reading of the options levels with a checked record of how often they held, whale wallet positions on Hyperliquid, and alerts in Telegram.

Use both if you already pull Laevitas data and want an independent, graded second opinion on expiry levels. Our live boards are free, so the overlap costs nothing.

FAQ

What is Laevitas?

A crypto derivatives data platform covering options, perpetuals and dated futures across 15+ exchanges, with dashboards, an API and an MCP server. It has a free tier with one week of history; paid plans start at $50 per month per seat.

Is there a free alternative to Laevitas?

For BTC and ETH options levels, yes: our max pain, option walls, gamma and volatility boards are free, without an account. For multi-venue raw data and an API there is no full free substitute; Laevitas's own free tier is the closest.

Does Laevitas show max pain?

Yes. Its API documentation includes historical max pain by market and currency, along with GEX and open interest by strike.

Does max pain actually work?

Mostly not as a magnet. On 466 BTC and ETH expiries since March 2026, price settled within 1% of max pain only 37% of the time. The full ledger is public on /en/docket.

Laevitas or INDICIA: which is cheaper?

Laevitas Premium is $50 per month per seat; Enterprise with the historical API is $500. INDICIA's live boards are free, paid tiers are $39 and $99 per month, and the Expiry Brief is $15 per month. They are different products: Laevitas sells data, we sell checked readings.

Does INDICIA have an API?

No. We do not sell the raw database. If you need an API, Laevitas is the better choice.

⚠️ Honest about our own limits: two assets, one options venue for the ledger (Deribit, roughly 29% of ETH options) and no API. If your work needs many venues, altcoins or raw data, Laevitas fits that job better. A system decision log, not investment advice.

Check the record before you pay anyone

The ledger of 466 expiries, today's max pain, walls and gamma are free to look at. Paid tiers add the same-morning reading and the whale structure sizes.

Open the max pain ledger →

Laevitas is a trademark of its respective owner. INDICIA DESK is an independent project and is not affiliated with or endorsed by Laevitas. Statements about Laevitas describe its public website, pricing page and API documentation as of 24 Oct 2026. Not financial advice. © 2026 INDICIA DESK.